UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Deciding between cash back and rewards credit cards? This guide helps you compare features to find the best option for your financial goals.
26,399 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Geopolitics and energy markets collide as Iran-related headlines drive price moves. Investors are reassessing risk, h...
A hedge fund manager publicly admits that his temperament blocks Buffett-style value investing. The admission highlig...
The US Senate is weighing a broad idle-stablecoin yield ban, pushing industry players toward AI-driven Yield-as-a-Ser...
Fidelity has alerted owners of 500-stock funds that the S&P 500 is dominated by a small group of mega-caps, raising q...
As 2026 reshapes real estate marketing, a new ranking spotlights the 10 best real estate marketing firms. Agents and ...
As AI reshapes markets and policy, this analysis draws lessons from America's founding framework to guide personal fi...
EU DAC8 and UK CARF rules are now driving tax reporting for 2027. As providers capture 2026 activity, investors shoul...
The iconic Atari brand is tapping public investors to back the first Atari Hotel, a Phoenix project blending gaming, ...
March 2026 brings a wave of Koyfin alternatives as traders seek deeper data, faster alerts, and cleaner interfaces. H...
A small auto-enrollment default in 401(K) plans can cost the average saver hundreds of thousands over a lifetime, a n...
A rare signal has emerged as markets hit new highs. This article explains what a stock market flashing warning could ...